Format

Send to

Choose Destination
See comment in PubMed Commons below
Influenza Other Respir Viruses. 2013 Nov;7(6):1380-9. doi: 10.1111/irv.12129. Epub 2013 Jul 5.

Factors influencing infection by pandemic influenza A(H1N1)pdm09 over three epidemic waves in Singapore.

Author information

1
Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore; Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, Singapore.

Abstract

INTRODUCTION:

Previous influenza pandemics had second and on occasion third waves in many countries that were at times more severe than the initial pandemic waves.

OBJECTIVE:

This study aims to determine the seroepidemiology of successive waves of H1N1pdm09 infections in Singapore and the overall risks of infection.

METHODS:

We performed a cohort study amongst 838 adults, with blood samples provided upon recruitment and at 5 points from 2009 to 2011 and tested by haemagglutination inhibition (HI) with A/California/7/2009 (H1N1pdm09). Surveys on key demographic and clinical information were conducted at regular intervals, and associations between seroconversion and these variables were investigated.

RESULTS:

After the initial wave from June to September 2009, second and third waves occurred from November 2009 to February 2010 and April to June 2010, respectively. Seroconversion was 13·5% during the first wave and decreased to 6·2% and 6·8% in subsequent waves. Across the three waves, the elderly and those with higher starting HI titres were at lower risk of seroconversion, while those with larger households were at greater risk. Those with higher starting HI titres were also less likely to have an acute respiratory infection.

CONCLUSIONS:

The second and third waves in Singapore had lower serological attack rates than the first wave. The elderly and those with higher HI titres had lower risk, while those in larger households had higher risk of seroconversion.

KEYWORDS:

Epidemic waves; H1N1pdm09; haemagglutination inhibition; risk factors; seroconversion; seroepidemiology

PMID:
23829633
PMCID:
PMC4634269
DOI:
10.1111/irv.12129
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley Icon for PubMed Central
    Loading ...
    Support Center